Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
09 mai 2023 06h50 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that the U.S. Food and Drug...
Synthetic Biology Market is Poised to Thrive at CAGR of 21.4 % CAGR During 2023 to 2031 | TMR Report
19 avr. 2023 15h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 20, 2023 (GLOBE NEWSWIRE) -- The global synthetic biology market is anticipated to grow at a 21.4% CAGR from 2023 to 2031. A market valuation of US$ 74.7...
Synthetic Biology Market Size & Share to Surpass $85.97 Billion by 2030 | Vantage Market Research
17 avr. 2023 06h34 HE
|
Vantage Market Research
WASHINGTON, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Synthetic Biology Market is valued at USD 12.70 Billion in 2022 and is projected to attain a value of USD 85.97 Billion by 2030 at a CAGR of...
Global Food Biotechnology Market Report 2023: Rising Need to Improve Yield And Quality of Food Products Drives Demand
13 avr. 2023 05h38 HE
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Global Food Biotechnology Market (2023-2028) by Type, Application, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending...
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
31 mars 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp®...
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
29 mars 2023 06h40 HE
|
Synlogic, Inc.
– Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and SYNB1353 for homocystinuria (HCU)...
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria
28 mars 2023 06h52 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that the European Medicines...
Gene Synthesis Market Size & Share to Surpass $6.58 Billion by 2028 | Vantage Market Research
27 mars 2023 07h02 HE
|
Vantage Market Research
WASHINGTON, March 27, 2023 (GLOBE NEWSWIRE) -- Global Gene Synthesis Market is valued at USD 2.16 Billion in 2021 and is projected to reach USD 6.58 Billion by 2028 at a CAGR (Compound Annual Growth...
Gene Synthesis Market Size to Cross USD 14.2 Bn by 2033 with CAGR of 23.6% | Transparency Market Research
21 mars 2023 09h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, The global gene synthesis market stood at US$ 1.6 Billion in 2023 and the industry...
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
20 mars 2023 06h55 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 20, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, announced that positive data from the...